SMC Decisions — 13 July 2026

SMC Decisions — 13 July 2026 The Scottish Medicines Consortium published advice on six medicines on 13 July 2026. Five, which appear to be high cost drugs, were accepted. (Fezolinetant list price in the UK has not been confirmed publicly, but comparable products in the US cost approximately $10,000–15,000 per year. It is accepted within […]

UK–US Trade Agreement and July Developments

UK–US Trade Agreement and July Developments On 2 July 2026, the Department of Health announced a series of fast-track drug access pilots from September 2026. 1 These pilots add to the cost pressures brought about by the NICE cost-effectiveness threshold increase to £25,000–£35,000 per QALY which took effect in April 2026, and the commitment under the […]